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Abstract
The twin-arginine translocation (Tat) pathway is well known for its ability to export fully folded substrate proteins out of the
cytoplasm of Gram-negative and Gram-positive bacteria. Studies of this mechanism in Escherichia coli have identified
numerous transient protein-protein interactions that guide export-competent proteins through the Tat pathway. To
visualize these interactions, we have adapted bimolecular fluorescence complementation (BiFC) to detect protein-protein
interactions along the Tat pathway of living cells. Fragments of the yellow fluorescent protein (YFP) were fused to soluble
and transmembrane factors that participate in the translocation process including Tat substrates, Tat-specific proofreading
chaperones and the integral membrane proteins TatABC that form the translocase. Fluorescence analysis of these YFP
chimeras revealed a wide range of interactions such as the one between the Tat substrate dimethyl sulfoxide reductase
(DmsA) and its dedicated proofreading chaperone DmsD. In addition, BiFC analysis illuminated homo- and hetero-
oligomeric complexes of the TatA, TatB and TatC integral membrane proteins that were consistent with the current model
of translocase assembly. In the case of TatBC assemblies, we provide the first evidence that these complexes are co-localized
at the cell poles. Finally, we used this BiFC approach to capture interactions between the putative Tat receptor complex
formed by TatBC and the DmsA substrate or its dedicated chaperone DmsD. Our results demonstrate that BiFC is a powerful
approach for studying cytoplasmic and inner membrane interactions underlying bacterial secretory pathways.
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Introduction
The bulk of protein transport across the inner membrane of
Gram-negative bacteria occurs via the well-characterized Sec
export pathway [1–4]. Sec export involves the membrane
translocation of polypeptides that are largely unfolded and
effectively ratchet their way through the Sec pore in a process
requiring ATP hydrolysis [5,6]. A fundamentally different
pathway known as the twin-arginine translocation (Tat) system
operates alongside the Sec pathway. The hallmark of the Tat
pathway that distinguishes it from the Sec mechanism is the ability
to transport proteins of varying dimension that have acquired a
largely, if not completely, folded conformation [7–10]. Studies on
the Tat mechanism have demonstrated that the integral
membrane proteins TatA, TatB, and TatC form the minimal
components necessary for exporting folded proteins in E. coli. The
TatA and TatB components are single-span integral membrane
proteins while TatC has been shown to contain six transmem-
brane spans [11]. These membrane proteins have been observed
to form two distinct complexes: one that is comprised of multiple
subunits of TatA and a second that contains predominantly TatB
and TatC [12–14]. TatA homo-oligomers form a variable
diameter ring structure that may serve as a protein-conducting
channel [15] or a patch that facilitates translocation by local
destabilization of the bilayer [16]. The TatB and TatC proteins
form a complex to which substrates initially bind [17], suggesting
that TatBC serves as the twin-arginine signal peptide binding site.
Proteins that transit the Tat pathway do so because they fold too
rapidly to remain competent for Sec-dependent export [18] or
because they bind protein subunits [9,19] and/or redox cofactors
[20], such as FeS clusters or molybdopterin centers, in the
cytoplasm. This raises the important question of how the Tat
pathway determines whether a substrate is sufficiently folded,
including the assembly of subunits or cofactors, prior to the
membrane translocation step. At least three mechanisms operate
prior to, or concomitant with, translocation through the Tat pore
that serve to prevent wasteful or harmful export of premature or
improperly folded substrates. First, a folding quality control
mechanism has been proposed on the basis that misfolded or
partially folded proteins are not exported via the Tat pathway
[7,21–23]. Recent evidence suggests that the Tat translocase itself
apparently ‘‘senses’’ the substrate folded state [24]. Second, Tat
export is regulated at an earlier stage by additional ‘‘proofreading’’
factors that recognize specific Tat signal peptides and/or mature
domains. These factors include dedicated chaperones such as
DmsD and TorD that coordinate the cofactor-insertion and export
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SlyD) that affect the stability and targeting of certain substrates
[26–28]. Third, the Tat apparatus appears to directly initiate the
turnover of rejected substrate molecules [29].
Direct visualization of the molecular interactions between
proteins can reveal important details about how protein-protein
interactions execute and regulate a wide range of events inside
living cells. A number of fluorescence-based methods have been
developed and widely used for visualizing and identifying
interacting proteins including fluorescence resonance energy
transfer (FRET) [30,31] and bimolecular fluorescence comple-
mentation (BiFC) [32,33]. In the case of BiFC, a fluorescent
protein is split into two non-fluorescent fragments that are fused to
a pair of interacting proteins. Interaction of the two proteins brings
the split fragments into close proximity, resulting in reassembly of
the fluorescent protein. Hence, reconstituted fluorescence is
coupled to the interaction of the two proteins and can be used
to conveniently determine how, when and where two proteins
interact inside living cells. The power of this technique for
capturing interactions along the secretory pathway of mammalian
cells was first demonstrated by Michnick and coworkers [34]. In a
similar vein, we demonstrate here that BiFC enabled visualization
of a wide range of protein-protein interactions that constitute early
steps in the Tat translocation cycle. We focused on interactions
that had previously been established by alternative techniques or
for which previous studies had led to conflicting results. These
included: (i) the binding between soluble proteins such as the Tat
substrate dimethyl sulfoxide reductase (DmsA) with its dedicated
proofreading chaperone DmsD; (ii) the assembly of transmem-
brane proteins such as TatA with itself or TatB with TatC; and (iii)
the targeting of soluble proteins to transmembrane subunits such
as DmsA docking on TatC. Our results confirm that BiFC is a
powerful tool for molecular dissection of key mechanistic steps of
the Tat export process and provide the first robust screening
platform of protein-protein interactions along this important
pathway.
Results
Development of BiFC for Tat Substrate-Chaperone
Interactions
To visualize protein interactions between soluble and trans-
membrane factors that participate in various steps of the Tat
export process, we employed BiFC based on split fragments of
enhanced yellow fluorescent protein (YFP). Our first target was the
well-characterized interaction between E. coli DmsA and its
cognate binding chaperone DmsD (Fig. 1a). The DmsD
chaperone recognizes the DmsA twin-arginine signal peptide
[26] and helps orchestrate the biogenesis and assembly of the
DmsA enzyme [35]. It has been suggested that this interaction
serves as a proofreading step that prevents premature export of
incompletely folded DmsA [36,37]. Since the DmsA signal peptide
(ssDmsA) alone is sufficient to interact with DmsD [26], we first
tested whether ssDmsA fused to the N-terminal YFP fragment
(ssDmsA-Y1) interacted with DmsD fused to the C-terminal YFP
fragment (DmsD-Y2). As evidenced by fluorescence microscopy,
wt TG1 cells expressing these two chimeras emitted strong
fluorescence (Fig. 2a) that was nearly 5 times brighter than the
background from control cells co-expressing an unfused version of
Y1 with DmsD-Y2 (Fig. 2b). The low levels of background
fluorescence observed for control cells was likely due to self-
assembly of the YFP fragments in the cytoplasm. An equally strong
fluorescent phenotype was observed when the same constructs
were expressed in a DtatC derivative of TG1 that is incapable of
Tat-specific transport (Fig. 2a and b), indicating that the
interaction was not dependent on a functional Tat system (see
below). Importantly, when ssDmsA was replaced with the Sec-
dependent PhoA signal peptide (ssPhoA), no fluorescence above
background was observed (Fig. 2a and b) verifying that the
fluorescence seen following co-expression of ssDmsA-Y1 and
DmsD-Y2 was highly specific for the ssDmsA-DmsD interaction.
It is noteworthy that replacement of the YFP fragments with
similarly designed fragments derived from a monomeric variant of
RFP [38] gave nearly identical complementation results for the
ssDmsA-DmsD interaction (Fig. S1). This suggests that the BiFC
signal seen above was due to the specificity of this tandem
chaperone/signal peptide system and was not an artifact of the
split reporter protein.
To address whether the engineered ssDmsA-Y1 chimera was
still faithfully recognized and exported to the periplasm by the Tat
translocase, we determined the subcellular location of ssDmsA-Y1
following its co-expression with DmsD-Y2 in wt or DtatC cells. As
expected, a portion of the ssDmsA-Y1 was localized to the
periplasm in wt cells but not in tatC-deficient cells (Fig. 2c). For
comparison, DmsD-Y2 was observed exclusively in the cytoplasm
of both these strains (Fig. 2c). It should be noted that the Sec-
dependent substrate ssPhoA-Y1, like its ssDmsA-Y1 counterpart,
accumulated in both the cytoplasm and the periplasm of wt cells
(Fig. 2c), indicating that the lack of YFP complementation for the
ssPhoA-Y1 construct was not due to poor expression/stability or to
highly efficient translocation via the Sec pathway. Taken together,
these results indicate that ssDmsA-Y1 is capable of transiting the
Tat pathway.
Tat Substrate-Chaperone Interactions Do Not Require
the TatABCE Proteins
We next sought to determine whether binding of DmsA by its
cognate chaperone DmsD required the TatABCE proteins that
comprise the translocase or instead was uncoupled from these
components. Following co-expression of ssDmsA-Y1 and DmsD-
Y2 in various tat-deficient strain backgrounds, we observed
significant binding of ssDmsA by DmsD even when the Tat
system was partially (DtatE) or completely (DtatB, DtatC, DtatAE
and DtatABCE) inactivated (Fig. 3a). In addition to the ssDmsA-Y1
reporter protein, we constructed a chimera comprised of the entire
DmsA enzyme (DmsA-Y1) to determine if the BiFC could be used
to evaluate the binding of full-length Tat substrates by proofread-
ing chaperones. Co-expression of DmsA-Y1 with DmsD-Y2 in wt
cells resulted in a fluorescent signal that was significantly above
background but only about 50% of that observed for the ssDmsA-
Y1/DmsD-Y2 pair (Fig. 3b). We attribute this decrease to the
lower level of soluble expression observed for the full-length
DmsA-Y1 construct compared to ssDmsA-Y1 (see Fig. S2d).
Similar to ssDmsA-Y1, DmsA-Y1 interacted strongly with DmsD
in various tat-deficient mutants (Fig. 3b). Overall, our BiFC results
are entirely consistent with the view that proofreading chaperones
operate at an early stage of Tat export and their substrate binding
activity is uncoupled from the membrane translocation step [36].
To verify that the BiFC signals from the DmsA/DmsD
interactions were due to physical association between the proteins,
we performed a co-purification experiment using an 8x polyhisti-
dine-tagged version of DmsD-Y2. Co-expression of this construct
with ssDmsA-Y1 or DmsA-Y1 in TG1 DtatABCE cells was per-
formed, followed by Ni-NTA chromatography. SDS-PAGE
analysis of the elution fractions collected from the column revealed
that these fractions contained both the 8xHis-DmsD-Y2 and
DmsA-Y1 (Fig. S2a) or ssDmsA-Y1 (data not shown). Moreover,
all of the elution fractions were fluorescent, indicating that the
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DmsA-Y1 (Fig. S2b). Native PAGE analysis of the elution fractions
revealed fluorescent complexes that migrated at the expected sizes
for DmsA-Y1/8xHis-DmsD-Y2 and ssDmsA-Y1/8xHis-DmsD-Y2
(Fig. S2c). Western blot analysis of these same fractions confirmed
the presence of the DmsA-Y1 or ssDmsA-Y2 fusion proteins in
these affinity-captured complexes (Fig. S2d). Similar co-purification
results were obtained using versions of DmsA or DmsD that lacked
the Y1 fragments (data not shown), although the purified complexes
were of course not fluorescent and the yield was lower. We suspect
that the higher yield for Y1/Y2-containing complexes was the result
of intermolecular stabilization or trapping afforded by the nearly
irreversible assembly of the split YFP fragments. As such, the use of
YFP fragments may be a convenient strategy for co-purification of
interacting proteins, especially those whose association in the cell is
short-lived. Overall, these results indicate that the BiFC signals
Figure 1. Protein interactions detected via BiFC along the Tat pathway of E. coli. Splitting YFP into fragments Y1 and Y2 can be used to
visualize interactions between: (a) two soluble cytoplasmic proteins; (b) a transmembrane protein with itself; (c) two different transmembrane
proteins; and (d) a soluble cytoplasmic protein and a transmembrane protein.
doi:10.1371/journal.pone.0009225.g001
Imaging Tat Interactions
PLoS ONE | www.plosone.org 3 February 2010 | Volume 5 | Issue 2 | e9225observed above were due to authentic association between the
substrate/chaperone pair.
Specificity Determinants of Substrate-Chaperone
Interactions
Using our BiFC system, we next explored the substrate
specificity of the DmsD proofreading chaperone. First, we tested
whether the twin-arginine residues in ssDmsA, which are needed
for functional Tat transport, were required for DmsD binding and
in turn the BiFC signal. For this, we generated variants of ssDmsA-
Y1 and DmsA-Y1 in which the twin-arginine residues in the
(S/T)RRxFLK consensus motif were each mutated to lysine, a
Figure 2. BiFC illuminates DmsA-DmsD interaction. (a) Fluores-
cence microscopy of wt TG1 cells expressing ssDmsA-Y1/DmsD-Y2 (left),
TG1 DtatC cells expressing ssDmsA-Y1/DmsD-Y2 (center), and wt TG1
cells expressing ssPhoA-Y1/DmsD-Y2 (right). (b) Flow cytometric
analysis of cells expressing constructs as indicated. Median fluorescence
was obtained for each cell population and normalized to the median
fluorescence measured for TG1 cells expressing ssDmsA-Y1/DmsD-Y2
(median fluorescence value for this interaction was M=2247). Data was
reported as the average of 6 replicate experiments (n=6) and error bars
represent the standard error of the mean (sem). (c) Western blot
analysis of periplasmic (per) and cytoplasmic (cyt) fractions from wt TG1
or TG1 DtatC cells expressing ssDmsA-Y1/DmsD-Y2 or ssPhoA-Y1/
DmsD-Y2 as indicated. YFP1 was detected by virtue of a C-terminal
FLAG tag using anti-FLAG antibody. YFP2 and GroEL proteins were
detected using anti-GFP or anti-GroEL antibodies, respectively.
doi:10.1371/journal.pone.0009225.g002
Figure 3. Specificity determinants of substrate/chaperone
interactions. Co-expression of (a) ssDmsA-Y1/DmsD-Y2 or (b) DmsA-
Y1/DmsD-Y2 in various TG1 tat deletion strains as indicated. TG1 (2)
indicates cells that co-expressed Y1 lacking the ssDmsA signal peptide
and DmsD-Y2. Median cell fluorescence was obtained via flow
cytometry and normalized to that for wt TG1 cells co-expressing
ssDmsA-Y1/DmsD-Y2. Data was reported as the average of 6 replicate
experiments (n=6) and error bars represent the sem. (c) Co-expression
of DmsD-Y2 with wt ssDmsA-Y1, full-length DmsA-Y1, or twin-lysine
(KK) variants of ssDmsA-Y1 or DmsA-Y1 in a wt TG1 background.
Chaperones DmsD and TorD each fused to Y2 were co-expressed with
their cognate or non-cognate signal sequences (ssDmsA-Y1, ssTorA-Y1,
ssNarG-Y1). Median cell fluorescence was obtained via flow cytometry
and normalized to that for wt TG1 cells co-expressing ssDmsA-Y1/
DmsD-Y2. Data was reported as the average of 6 replicate experiments
(n=6) and error bars represent the sem.
doi:10.1371/journal.pone.0009225.g003
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ssDmsA(KK)-Y1 was co-expressed with DmsD-Y2 in wt TG1
cells there was no significant difference in cell fluorescence. This
result was consistent with in vitro binding results observed for
ssTorA(KK), which displayed identical TorD binding character-
istics to its twin-arginine counterpart [25]. Cells co-expressing full-
length DmsA(KK)-Y1 were also fluorescent although less so than
their twin-arginine counterpart (Fig. 3c), suggesting that regions of
the mature portion of DmsA may play a role in DmsD specificity.
Our results with both the ssDmsA and full-length DmsA constructs
support the conclusion that the twin-arginine motif itself is clearly
not the overarching signal recognition factor.
To determine whether the DmsD chaperone was specific for its
cognate substrate or instead exhibited promiscuity as has been
seen previously [26,41], we cloned the signal peptides from the Tat
substrates DmsA, TorA and NarG as fusions with the Y1
fragment. Following co-expression of these constructs with
DmsD-Y2 in wt TG1 cells, a strong BiFC signal was observed
only for the ssDmsA-Y1/DmsD-Y2 pair (Fig. 3c). It should be
noted that the exquisite specificity observed here for DmsD was
not observed in earlier studies where DmsD was reported to bind
signal peptides derived from DmsA and TorA [26,41]. However,
in vivo complementation assays with authentic DmsA and TorA
substrates revealed that DmsD and TorD cannot replace one
another [42], suggesting that substrate promiscuity of DmsD may
be an artifact of the experimental conditions used to investigate
signal peptide-chaperone binding. Even our assay was not immune
to this sort of artifact as testing of TorD-Y2 against the same set of
signal peptides revealed a BiFC signal for both the cognate
ssTorA-Y1 and the non-cognate ssDsmA-Y1 constructs (Fig. 3c).
Nonetheless, our results provide further evidence that the BiFC
strategy enables direct detection of interactions between different
chaperones/signal peptide pairs directly in E. coli without needing
to alter the geometry (e.g., linker lengths) or orientation (N- versus
C-terminal) of the YFP fragments.
Identification of Permissive Residues in DmsD Binding
Pocket
To further demonstrate the utility of our BiFC assay, we attempted
to isolate gain-of-function DmsD variants that bind ssDmsA more
efficiently. Previous studies identified a ‘‘hot pocket’’ of residues in
DmsD that are important for signal peptide binding [43]. In this
study, a hyperbinding variant of DmsD carrying a single W87Y
substitution and a lower affinity variant, DmsD(R15C/L75S), were
reported. When the DmsD(R15C/L75S)-Y2 variant was co-
expressed with ssDmsA-Y1, there was a clear decrease in the BiFC
signal compared to wt DmsD (Fig. S3a), consistent with the earlier
report. However, binding activity of DmsD(W87Y)-Y2 was indistin-
guishable from wt DmsD (Fig. S3a). Therefore, to experimentally
identify residues in this region of DmsD that permitted signal peptide
binding, we created 2 random libraries of DmsD variants using an
NNK library approach that targeted residues W72/L75/F76 in the
putative binding pocket [43]. The resulting DmsD libraries were
screened via fluorescence-activated cell sorting (FACS) using either
ssDmsA-Y1 or full-length DmsA-Y1 as the co-expressed partner. As
seen in Table 1, a strong bias for hydrophobic, uncharged residues in
these positions was observed, especially in positions 72 and 76 where
a hydrophobic residue was found in 16/21 and 19/21 clones,
respectively (7 and 10 of these, respectively, were wt in this position).
Position 75 appears to be the most flexible as more than half of the
clones carried a hydrophilic residue in this position, and in 2 of these
cases the residue was charged (Lys, Asp). It is noteworthy that the
BiFC signals emitted by all the isolated clones were comparableto the
signal seen for wt DmsD(WLF)-Y2, except for DmsD(HYF) which
exhibited a gain-of-function phenotype (Fig. S3a). We attribute this
increased fluorescence to improved substrate binding because the
expression level of each clone was unchanged relative to wt DmsD
(Fig. S3c). Interestingly, much less structural variability was tolerated
for these residues in DmsD when full-length DmsA-Y1 was used as
substrate (Table 1). This suggests that substrate binding specificity is
dependent on the context of the signal peptide and that the sequence
Table 1. Isolation of permissive residues in the putative binding pocket of DmsD.
DmsD clone Binding partner Sequence # of times isolated ssDmsA binding activity* DmsA binding activity*
wild-type ssDmsA 71 AWQRLFV 77 1 1.00 0.62
HYF ssDmsA -H--YF- 2 1.48 0.67
YLF ssDmsA -Y--LF- 1 0.92 0.81
IVT ssDmsA -I--VT- 1 1.21 0.46
FYL ssDmsA -F--YL- 1 1.22 0.84
FDL ssDmsA -F--DL- 1 1.20 nd
FAP ssDmsA -F--AP- 1 0.90 nd
FQM ssDmsA -F--QM- 1 0.87 nd
VKM ssDmsA -V--KM- 1 1.09 nd
SNI ssDmsA -S--NI- 1 1.11 nd
SPH ssDmsA -S--PH- 1 1.09 nd
wild-type DmsA 71 AWQRLFV 77 1 1.00 0.62
WMF DmsA -W--MF- 2 nd 0.63
WYF DmsA -W--YF- 2 nd 0.73
WFF DmsA -W--FF- 1 nd 0.59
FHL DmsA -F--HL- 1 nd 0.48
FHP DmsA -F--HP- 1 nd 0.46
FFP DmsA -F--FP- 1 nd 0.45
*Values are the average of six replicate experiments and the standard error of the mean (sem) is less than 15% in each case.
doi:10.1371/journal.pone.0009225.t001
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specific compared to the signal peptide alone. In support of this
notion, the most interesting clones in the context of ssDmsA-Y1 (e.g.,
DmsD(R15C/L75S) and DmsD(HYF)) produced BiFC signals that
were indistinguishable from wt DmsD when full-length DmsA-Y1
was the substrate (Fig. S3b).
Detection of Interactions between Transmembrane
Components of the Tat Translocase
Previous studies have established that each of the Tat
components form stable, defined, homo-multimeric complexes
[13,14,44–48]. Hence, we next tested whether BiFC could be used
to detect interactions between the integral TatABC membrane
proteins that comprise the translocase and are essential for Tat
export (see Fig. 1b and c). For these experiments, each Tat gene
was cloned as a fusion to both Y1 and Y2 (e.g., TatA-Y1 and
TatA-Y2) and expressed in TG1 cells lacking the tatABCE genes.
We chose a strain background lacking all tat genes because
previous studies have shown that self-assembly of individual Tat
components does not strictly require any of the other Tat
components [44–47]. In the case of TatA, we observed a BiFC
signal that was 2–3 fold above the negative controls (Fig. 4a), albeit
an order of magnitude lower than that seen for the ssDmsA/
DmsD interaction described above. Co-expression of a TatA
mutant with a substitution in the predicted amphipathic region
(F39A) that blocks translocation activity and leads to aberrant
TatA oligomers [49] was still able to assemble with wt TatA
(Fig. 4a). Interestingly, co-expressed F39A-Y1 and F39A-Y2 were
observed to homo-oligomerize very efficiently, with a BiFC signal
that was nearly twice as fluorescent as the wt TatA homo-
oligomers (Fig. 4a).
To test assembly of the TatA BiFC constructs under more
physiologically relevant conditions, we co-expressed TatA-Y1/
TatA-Y2 in TG1 DtatAE cells that express native TatB and TatC
Figure 4. Visualizing the formation of TatA homo-oligomers. (a) Cell fluorescence of TG1 DtatABCE cells expressing TatA-Y1, TatA-Y2, F39A-
Y1, F39A-Y2, and the negative controls Y1 or Y2. Median fluorescence values were obtained via flow cytometric analysis and reported as the average
of 3 replicate measurements (n=3). Error bars represent the sem. (b) Bright field illumination and fluorescence microscopy for phenotypic analysis of
chain complementation and fluorescence localization in TG1 DtatAE cells expressing various TatA chimeras as indicated.
doi:10.1371/journal.pone.0009225.g004
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compared to controls (Fig. 4b) that was quantitatively similar to
the BiFC signal seen in DtatABCE cells (data not shown). It should
be noted that the fluorescence appeared predominantly at the cell
poles, consistent with earlier TatA labeling studies [50]. To
confirm that the TatA-Y1 and TatA-Y2 chimeras were able to
form functional translocases, we examined these cells by light
microscopy. It is well known that tat-deficient strains form chains
of up to 15 cells [51]. This cell division defect results from the
mislocalization of two Tat-dependent amidases, AmiA and AmiC,
which have been implicated in cleavage of the septum during cell
division [52]. We observed that TatA-Y1 and TatA-Y2 are able to
form functional translocases with endogenous TatB and TatC as
evidenced by the ability of these constructs to reverse the chain
phenotype of DtatAE cells (Fig. 4b). In contrast, co-expression of
TatA(F39A)-Y1 and TatA(F39)-Y2 did not reverse the chain
phenotype of DtatAE cells (Fig. 4b), even though these constructs
yielded strong BiFC fluorescence that accumulated at the cell poles
of DtatABCE cells (Fig. 4a). Taken together, these results indicate
that the export defect of TatA(F39A) mutants does not arise from
an inability of to self-assemble. Similar self-assembly studies were
performed for TatB and TatC. Co-expression of TatB-Y1/TatB-
Y2, but not TatC-Y1/TatC-Y2, in DtatABCE cells resulted in a
BiFC signal (Fig. 5a). The lack of BiFC for TatC-Y1/TatC-Y2 was
not attributable to instability or inactivity of the TatC fusions, or
low production of TatC caused by its overexpression [47], because
these chimeras formed functional translocases as evidenced by
their ability to reverse the chain phenotype of DtatC cells (data not
shown).
We next investigated the formation of hetero-multimeric
complexes among the various Tat components. Co-expression of
different pairs of Tat components (e.g., TatA-Y1 + TatC-Y2) in
cells lacking the native tat genes resulted in strong BiFC signals for
TatA-Y1/TatC-Y2 and TatB-Y1/TatC-Y2 and a weaker signal
for the TatA-Y1/TatB-Y2 that were all 3–4 times more
fluorescent than the respective negative controls (Fig. 5a). These
results were entirely consistent with earlier findings that TatB and
TatC form a complex containing multiple copies of each subunit
[12] that serves as the binding site for Tat substrates [17,53], and
that TatB is capable of interacting with TatA even in the absence
of TatC [14]. Importantly, switching the Y1 and Y2 fusion
partners corroborated the BiFC signals measured for TatA-Y2/
TatC-Y1 and TatB-Y2/TatC-Y1 (Fig. 5a). However, the TatA-
Y2/TatB-Y1 signal was indistinguishable from the control (data
not shown). This result together with the relatively low signal seen
above for TatA-Y1/TatB-Y2 suggests that the TatA-TatB
interaction may be considerably weaker than that of TatA-TatC
and TatB-TatC. We also tested two TatC variants: TatC(P48A)
carries a substitution in the first periplasmic loop region that
abolishes export and partially impairs TatC interaction with TatB
[49] and TatC(E103R) has a substitution in the first cytoplasmic
loop between predicted transmembrane helices II and III that
blocks export but does not affect TatBC complex formation [54].
In line with these earlier observations, both the TatC(P48A) and
TatC(E103R) constructs produced BiFC signals when co-
expressed with TatB, however the TatC(P48A) signal was weaker
than the signals measured for the interaction between TatB and
either wt TatC or TatC(E103R) (Fig. 5a).
Fluorescence microscopy revealed that TatBC assemblies were
co-localized at the cell poles in both DtatABCE mutants and in the
single DtatB or DtatC deletion strains (Fig. 5b–d). This is the first
evidence of a polar location for TatBC complexes and is consistent
with earlier findings for the individual TatB and TatC proteins
[50]. Also evident in the microscopy analysis is the fact that all
TatB and TatC chimeras were able to complement the
corresponding single deletion strains (Fig. 5c and d). This
complementation required co-expression of both TatB and TatC
at nearly equal levels as independent expression of TatB or TatC
chimeras was unable to complement the chain phenotype of the
DtatB or DtatC cells, respectively (data not shown). Taken together,
these results indicate that Tat function was not impaired under
conditions of productive BiFC, but was highly sensitive to the
TatBC stoichiometry.
DmsA and DmsD Interact with the TatB and TatC
Proteins
As mentioned above, the TatBC complex has been implicated
as the substrate-binding site [17,53] and also as a possible docking
site for the DmsD chaperone [55]. Accordingly, we next
investigated interactions between the TatABC inner membrane
proteins and soluble cytoplasmic factors (see Fig. 1d). Following
co-expression of ssDmsA-Y1 with TatB-Y2 and TatC-Y2 in TG1
DtatABCE cells, a BiFC signal was observed that was 3.5- and
nearly 7-fold above background, respectively (Fig. 6a). A much
weaker but still significant BiFC signal was observed for full-length
DmsA-Y1, especially when co-expressed with TatC-Y2 (data not
shown). No signal above background was observed when ssDmsA-
Y1 was co-expressed with TatA-Y2 (data not shown). To
independently confirm the ssDmsA-Y1/TatC-Y2 interaction, we
isolated membrane fractions from DtatABCE cells and analyzed
these by Western blotting. When ssDmsA-Y1 was expressed alone,
we detected the fusion protein in the soluble fraction but not in the
membrane fraction (Fig. S4). However, when TatC-Y2 was co-
expressed, the ssDmsA-Y1 construct was found to co-localize in
the membrane fraction (Fig. S4) presumably due to its association
with TatC-Y2.
Interestingly,when the twin argininesinssDmsAweresubstituted
with lysines, the BiFC signal following co-expression of TatB-Y2
and TatC-Y2 increased to 5.4- and 10.7-fold above background,
respectively (Fig. 6a). This corroborates the recent observation that
the twin-arginine residues of the Tat consensus motif are not
essential for binding of precursor to the TatBC complex [54]. This
result is also consistent with the observation above that cytoplasmic
accumulation of non-exported substrates (e.g., ssDmsA(KK))
resulted in a stronger BiFC signal. When either TatC(P48)-Y2 or
TatC(E103R)-Y2 wasco-expressed with ssDmsA-Y1,we observed a
BiFC signal that was nearly 2-fold less fluorescent than that seen for
wt TatC. In the case of TatC(E103R), the reduced BiFC signal was
in close agreement with recent data indicating that this variant
exhibits reduced substrate binding[54].To test whether TatBC also
interacts with the DmsD chaperone, we co-expressed TatB-Y1 or
TatC-Y1 with DmsD-Y2 in DtatABCE cells. DmsD interaction with
TatB or TatC resulted in a ,2-4-fold increase in the BiFC signal
above background that was independent of the orientation of the
split fragments (Fig. 6b). Interestingly, the P48A substitution
resulted in a reduced BiFC signal while the E103R mutation
blocked interaction with DmsD (Fig. 6b), suggesting that these
residues, especially E103R, are important for the interaction of
DmsD with the TatC subunit of the translocase.
Discussion
Bacterial protein export requires a wide range of protein
interactions between soluble and transmembrane proteins, many
of which have been difficult to detect using traditional approaches
especially in the context of living cells. Here, we show that the YFP
BiFC overcomes these limitations and enables a detailed analysis
of numerous protein-protein interactions along the bacterial Tat
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PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e9225Figure 5. Assembly of fluorescent TatBC homo- and hetero-oligomers. (a) Cell fluorescence of TG1 DtatABCE cells expressing TatB and TatC
BiFC chimeras as indicated. In addition to wt TatC, the TatC variants P48A and E103R were also evaluated. Unfused Y1 and Y2 constructs co-expressed
with TatB or TatC chimeras served as negative controls. Median fluorescence values were obtained via flow cytometric analysis and reported as the
average of 3 replicate measurements (n=3). Error bars represent the sem. Bright field illumination and fluorescence microscopy for (b) TG1 DtatABCE,
(c) TG1 DtatB and (d) TG1 DtatC cells co-expressing TatB-Y1/TatC-Y2 or TatB-Y2/TatC-Y2 as indicated. Also shown are plasmid-free TG1 DtatB and
DtatC cells (control) to illustrate the chain phenotype of Tat-deficient mutants.
doi:10.1371/journal.pone.0009225.g005
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PLoS ONE | www.plosone.org 8 February 2010 | Volume 5 | Issue 2 | e9225Figure 6. BiFC reveals substrate and chaperone ‘‘docking’’ on TatB or TatC. (a) Cell fluorescence of TG1 DtatABCE cells co-expressing
ssDmsA-Y1 with either TatB-Y2 or TatC-Y2 as indicated. Also shown are data for the ssDmsA twin-lysine (KK) variant and the TatC variants P48A and
E103R. (b) TG1 DtatABCE cells co-expressing DmsD with either TatB or TatC chimeras as indicated. Unfused Y1 and Y2 constructs co-expressed with
TatB or TatC chimeras served as negative controls. Median fluorescence values were obtained via flow cytometric analysis and reported as the
average of 3 replicate measurements (n=3). Error bars represent the sem.
doi:10.1371/journal.pone.0009225.g006
Imaging Tat Interactions
PLoS ONE | www.plosone.org 9 February 2010 | Volume 5 | Issue 2 | e9225pathway of live cells. Among these were interactions between (i)
soluble cytoplasmic proteins, (ii) transmembrane proteins with
themselves or a different transmembrane protein; and (iii) soluble
cytoplasmic proteins and transmembrane proteins. Although not
tested here, we anticipate that specific interactions between
two soluble periplasmic proteins or a periplasmic protein with a
transmembrane protein will also be detectable by protein
fragmentation analysis. The challenge with detecting interactions
on the periplasmic side of the inner membrane is that YFP and its
relatives (e.g., GFP, CFP) do not attain a fluorescent conformation
in the periplasm [56] unless delivered there in an already folded
conformation via the Tat system [40,57,58]. Hence, assembly of
split fluorescent proteins in the periplasm may not yield a
fluorescent signal. One solution is to use split mRFP [38] (and
Fig. S1) since full-length mRFP can fold into a fluorescent
conformation in the E. coli periplasm (our unpublished observa-
tions). Alternatively, one could employ other protein fragment
complementation systems such as split b-lactamase that are
compatible with assembly and folding in the periplasm [59]. It is
also noteworthy that, even though not a problem in our studies,
the BiFC system could be further improved by increasing the
solubility of the split YFP fragments, especially Y1, using protein
engineering strategies. The reduced solubility of Y1 fusion proteins
can be partially offset by expressing these from a high-copy vector
while co-expressing Y2 chimeras from a low-copy vector, a
strategy that was used here and elsewhere [60].
We have shown that the BiFC system can be an effective tool for
confirming hypotheses regarding the Tat mechanism as well as for
generating new experimental insights on how the Tat system
functions. For instance, it is now generally accepted that several
layers of quality control regulate the export of Tat substrate proteins
[61]. The first layer, which we were able to visualize, is the
association of specific molecular chaperones (e.g., DmsD, TorD)
with Tat substrates. These interactions are thought to be important
in substrate folding as well as in preventing premature export of
improperly or incompletely folded proteins [26–28,62–64]. Our
results with ssDmsA-Y1 support the notion that substrate speci-
ficity of Tat chaperones is governed by the signal peptide, however
our data also indicate that the mature domain of DmsA makes an
important contribution to chaperone binding. In fact, there were a
few cases where we observed measurable differences for interac-
tions involving ssDmsA versus full-length DmsA, highlighting that
care should be taken when interpreting data from chaperone
binding experiments where signal peptides are used as surrogates
for the full-length preprotein substrate. The involvement of
chaperones has also led to the interesting hypothesis that these
proteins guide their substrates to the translocase. In support of this
hypothesis, biochemical studies revealed that DmsD interacted
tightly with the E. coli inner membrane and that the TatB and
TatC subunits were important for this interaction [55]. Our BiFC
results confirm that DmsD interacts specifically with TatB and
TatC (Fig. 6b), but not TatA (our unpublished observations). We
also observed that a small fraction of the ssDmsA/DmsD
complexes co-localized to the cell poles (Fig. 2a and also our
unpublished observations), which is also where the TatBC receptor
was observed to co-localize (Fig. 5b–d). These findings provide the
first genetic evidence that DmsD may play a role as a targeting
factor that delivers substrates to the TatBC receptor complex. To
confirm this, we are currently developing a three-way BiFC-based
FRET interaction system [65] to investigate whether DmsA/
DmsD/TatB (or TatC) form a ternary complex in living cells. A
final step prior to substrate export appears to be evaluation of a
substrate’s folding state by the Tat apparatus. Indeed, mounting
evidence indicates that the Tat system generally discriminates
against unfolded substrates [7,10,23,24] (although at least two
exceptions exist [16,66]) and it has been suggested that this folding
quality control may be performed directly by the Tat translocase
[24,29]. Thus, although not directly investigated here, we
anticipate that our BiFC system will enable genetic dissection of
this poorly understood aspect of Tat protein export and should
provide some insights into the path of a Tat precursor following its
recognition by TatBC up to a step where it is brought into close
vicinity of TatA.
Materials and Methods
Bacterial Strains, Plasmids, Growth and Induction
Conditions
The bacterial strains and plasmids used in this study are described
in Table 2. For cloning purposes, E. coli MC4100 cells were grown
aerobically in either liquid LB media or on solid LB media with agar
(LBA). For the BiFC assay, TG1 cells were made electrocompetent
by standard methods [67], transformed with equal plasmid
concentrations, and grown overnight on solid LB media and
antibiotics (BD Diagnostic Systems) at 37uC. The next morning
individual colonies were picked from the plates, placed into 3 mL of
liquid LB with antibiotics in 16–18 mm culture tubes, and grown
aerobically for 4 hrs at 37uC and 200 rpm until the optical density
reached OD600 ,0.5. Isopropyl b-D-thiogalactoside (IPTG) was
added to a final concentration of 1 mM for induction of protein
expression, the culture was then moved to a room temperature
incubator(20–24uC)at200 rpmforthenext8 hrs.Fluorescencewas
only measured for cells grown at room temperature. All single
knockout TG1 Tat mutantsweregenerated by P1transduction from
the Keio collection [68]. Strain TG1 DtatABCE was first created by
P1 transduction of DtatE::Kan
R from the Keio collection; the
kanamycin resistance was removed as described previously [69], and
P1 transduction was performed again from BW25113 DtatABC::aac
[70], however the apramycin resistance was not removed. Antibiotic
selection was maintained for all markers on plasmids at the following
concentrations: ampicillin (Amp), 100 mg/mL; chloramphenicol
(Cam), 20 mg/mL; kanamycin (Kan), 50 mg/mL; and tetracycline
(Tet), 10 mg/mL.
Construction of Plasmids
Plasmid pDmsDT25 was constructed previously by amplifying E.
coli dmsD from genomic DNA via PCR and cloning into the XbaI
and KpnI sites of pKNT25 [43]. The resulting plasmid harbors a
chimeric gene encoding dmsD fused to the T25 fragment of the
catalytic domain of Bordetella pertussis adenylate cyclase. Similarly,
plasmid pDmsALT18 was constructed previously by cloning a PCR
fragment encoding the signal peptide of E. coli dmsA (excluding the
signal peptide cleavage site) into the PstI and KpnI sites of pUT18
[43]. To establish the BiFC assay system, PCR fragments encoding
the N- (1–154 aa) and C-terminal (155–238 aa) halves of the
enhanced yellow fluorescent protein (YFP), abbreviated as Y1 and
Y2 respectively, were amplified from pIAF817YFP (a gift from Dr.
Rolf Morosoli). Plasmids pDmsD-Y2 and pssDmsA-Y1 were
constructed by replacing the T25 and T18 fragments in plasmids
pDmsDT25 and pDmsALT18 with Y2 and Y1, respectively. The
linker sequencesused for the fusion proteins were designed based on
those used by Hu et al. [32]. All further plasmid constructions used
in this study were based on these two initial plasmids. All plasmid
DNA constructs were verified by sequencing.
Fluorescence Analysis
After induction of protein expression, flow cytometric data was
collected on a FACSCalibur System (Becton Dickinson) at 0 and
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Strain or Plasmid Description Reference
Strain
MC4100 F’ araD139 D(argF-lac)U169 rpsL150 (Str
r) relA1 flbB5301 deoC1 ptsF25 rbsR Laboratory stock
TG1 F’ traD36 lacI
qD(lacZ) M15 proA
+B
+/supE D(hsdM-mcrB)5 (rk- mk- McrB
2) thi D(lac-proAB) Laboratory stock
TG1 DtatAE TG1 derivative lacking the tatA and tatE genes This study
TG1 DtatB TG1 derivative lacking the tatB gene This study
TG1 DtatC TG1 derivative lacking the tatC gene This study
TG1 DtatE TG1 derivative lacking the tatE gene This study
TG1 DtatABCE TG1 DtatE derivative with an apramycin marked deletion DtatABC::aac This study
Plasmid
pUT18 Plasmid containing T18 fragment of the catalytic domain of B. pertussis adenylate cyclase; Amp
R6 9
pKNT25 Plasmid containing T25 fragment of the catalytic domain of B. pertussis adenylate cyclase; Kan
R6 9
pDmsALT18 E. coli dmsA signal peptide inserted into pUT18
46
pDmsDT25 E. coli dmsD coding sequence inserted into pKNT25
46
pssDmsA-Y1 pDmsALT18 with T18 sequence replaced by sequence encoding YFP N-terminal fragment; FLAG tag epitope at 39 end This work
pDmsD-Y2 pDmsDT25 with T25 sequence replaced by sequence encoding YFP C-terminal fragment This work
p8xHis-DmsD-Y2 pDmsDT25 with N-terminal 8x polyhistidine tag and T25 sequence replaced by sequence encoding YFP
C-terminal fragment
This work
pY1 Control plasmid expressing Y1-FLAG; made by removing dmsA signal peptide sequence from pssDmsA-Y1 This work
pY2 Control plasmid expressing Y2; made by removing DmsD from pDmsD-Y2 This work
pssPhoA-Y1 pDmsA-Y1-FLAG with dmsA signal peptide sequence replaced by DNA encoding the signal peptide of the E. coli phoA gene This work
pDmsA-Y1 pssDmsA-Y1 with dmsA signal peptide sequence replaced by full-length E. coli dmsA; FLAG tag epitope at 39 end This work
pssDmsA(KK)-Y1 pssDmsA-Y1 with RR to KK substitution This work
pDmsA(KK)-Y1 pDmsA-Y1 with RR to KK substitution This work
pDnaK-Y2 pDmsD-Y2 with dmsD replaced by E. coli dnaK sequence This work
pTorD-Y2 pDmsD-Y2 with dmsD replaced by the E. coli torD sequence This work
pssTorA-Y1 pssDmsA-Y1 with dmsA signal peptide sequence replaced by E. coli torA signal peptide sequence This work
pssNarG-Y1 pssDmsA-Y1 with dmsA signal peptide sequence replaced by E. coli narG signal peptide sequence This work
pTatA-Y1 pssDmsA-Y1 with full-length E. coli tatA sequence in place of dmsA signal peptide sequence This work
pTatA-Y2 pDmsD-Y2 with the full length E. coli tatA sequence in place of dmsD This work
pF39A-Y1 pTatA-Y1 with F39A substitution This work
pF39A-Y2 pTatA-Y2 with F39A substitution This work
pTatB-Y1 pssDmsA-Y1 with full-length E. coli tatB sequence in place of dmsA signal peptide sequence This work
pTatB-Y2 pDmsD-Y2 with the full length E. coli tatB sequence in place of dmsD This work
pTatC-Y1 pssDmsA-Y1 with full-length E. coli tatC sequence in place of dmsA signal peptide sequence This work
pTatC-Y2 pDmsD-Y2 with the full length E. coli tatC sequence in place of dmsD This work
pP48A-Y1 pTatC-Y1 with P48A substitution This work
pP48A-Y2 pTatC-Y2 with P48A substitution This work
pE103R-Y1 pTatC-Y1 with E103R substitution This work
pE103R-Y2 pTatC-Y2 with E103R substitution This work
pDmsD-Y1 pssDmsA-Y1 with dmsD in place of dmsA signal peptide sequence This work
pR1 pY1 with mRFP1 Q66T N-terminus in place of Y1; FLAG epitope at 39 end This work
pR2 pY2 with mRFP1 Q66T C-terminus in place of Y2 This work
pssDmsA-R1 pssDmsA-Y1 with N-terminus of mRFP1 Q66T in place of dmsA signal peptide sequence This work
pDmsD-R2 pDmsD-Y2 with C-terminus of mRFP1 Q66T in place of dmsA signal peptide sequence This work
pDmsD-Y2 Tet
R Kan
R marker in pDmsD-Y2 replaced with Tet
R marker This work
pY2 Tet
R Kan
R marker in pY2 replaced with Tet
R marker This work
pTatB-Y2 Tet
R Kan
R marker in pTatB-Y2 replaced with Tet
R marker This work
pTatC-Y2 Tet
R Kan
R marker in pTatC-Y2 replaced with Tet
R marker This work
pP48A-Y2 Tet
R Kan
R marker in pP48A-Y2 replaced with Tet
R marker This work
pE103R-Y2 Tet
R Kan
R marker in pE103R-Y2 replaced with Tet
R marker This work
doi:10.1371/journal.pone.0009225.t002
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prepared by diluting 50 mL of live bacterial cells directly from
culture in 1 mL of 1x PBS. Median fluorescence was determined
from histograms of the cell fluorescence emitted by 30,000 viable
cells collected using the FACSCalibur flow cytometer in scan
mode. For microscopy, 15 mL of live bacterial cells directly from
culture were placed onto a microscope slide with cover slip. All
images were taken under oil immersion microscopy using a Zeiss
100x/1,30 lens. Microscopy was performed on a Zeiss Axioskop
40 equipped with a Zeiss 100x/1,30 Oil Plan-NEOFLUAR lens,
an X-Cite light source (EXFO, Mississauga, Ontario), a Semrock
Brightline filter cube for YFP emission (YFP-2427A-ZHE)
(Rochester, NY), digitally imaged with a SPOT FLEX digital
camera (Diagnostic Instruments, Inc.) and controlled with Spot
Imaging Software. All images captured under 100x-oil immersion
microscopy using the Zeiss 100x/1,30 Oil Plan-NEOFLUAR lens
were under bright field illumination (exposure 150 ms) or under
UV illumination (exposure 500 ms). For RFP analysis, see
Supplemental Methods S1.
DmsD NNK library construction and testing. Random
DmsD libraries were constructed by introducing diversity to the
W72/L75/F76 residues of the DmsD protein. Briefly, site-directed
random mutagenesis (Stratagene QuickChangeH Site-Directed
Mutagenesis Kit) of these residues was performed using degenerate
NNK primers to amplify dmsD from plasmid pDmsD-Y2. The
resulting DNA library was transformed into XL-1 Blue cells and
,10
5 clones (.3x coverage) were obtained. Library cells were
harvested, grown in liquid culture and plasmid DNA was isolated.
The isolated plasmid DNA library was digested with SphI and KpnI
to excise the diversified dmsD genes, which were subsequently
ligated into pDmsD-Y2 that had been similarly digested with SphI
and KpnI to remove wild-type (wt) dmsD. This was done to avoid
any potential mutations in the plasmid backbone that may have
been introduced during the site-directed mutagenesis reaction.
This library was isolated from cells and electroporated into TG1
cells that contained either pssDmsA-Y1 or pDmsA-Y1. This
library was spread on LBA plates supplemented with Amp and
Kan and incubated overnight at 37uC for resolution of
transformants. The cells were pooled into a 500 mL culture,
allowed to grow to OD600 ,0.5 at 37uC and 200 rpm, induced
with 1 mM IPTG at room temperature and 200 rpm for 8 hrs.
Aliquots of the culture were taken and resuspended in 1 mL of 1x
PBS and run through a FACSCalibur flow cytometer set for cell
recovery mode. The gate used on the FACSCalibur was set to
recover cells with a fluorescent signal greater than the ssDmsA-
Y1/DmsD-Y2 or DmsA-Y1/DmsD-Y2 BiFC signal. The
recovered cells were concentrated on 0.45 mm sterile membrane
filters (Whatman) and the membrane filters were transferred to
LBA + Amp/Kan plates to allow single colonies to grow overnight
at 37uC. Isolates from the overnight incubation were then picked
and grown in 96-well plates to an OD600 of ,0.5 at 37uC and
200 rpm, induced with 1 mM IPTG at room temperature and
200 rpm for 8 hrs and then checked for fluorescence using a
fluorescence microplate reader (Biotek Synergy HT) with
excitation filter 485/20 and emission filter 528/20. Cells with a
fluorescent signal greater than the ssDmsA-Y1/DmsD-Y2 or
DmsA-Y1/DmsD-Y2 signal were grown and plasmid was
harvested for DNA sequencing. Selected sequences are listed in
Table 1.
Cell fractionation and protein analysis. After 8 hrs of
induction, 1 mL of cells was collected and the OD600 was measured
using a spectrophotometer (Thermo Scientific Biomate3). The cells
were spun down for 2 min at 13,0006g and the supernatant was
removed. The periplasmic fraction from the E. coli cells was isolated
using a modified protocol of the Epicentre Biotechnologies
PeriPreps
TM Periplasting Kit (Madison, WI), where the
periplasting buffer did not contain any Ready-Lyse Lysozyme.
The soluble protein fraction from the periplasted E. coli cells was
isolated with BugBusterH Master Mix (Novagen) according to the
manufacturer’s protocol. For Western blotting, an equal volume of
2x SDS-PAGE buffer was added to the periplasmic and soluble
protein fractions and then boiled for 15 min at 100uC. Samples
were loaded onto 4–20% iGels (NuSep Ltd, Australia) where
protein amount was normalized to the optical density of the cells
taken before fractionation. After SDS-PAGE, the proteins were
transferred to Immobilon-P PVDF 0.45 mm membrane (Millipore,
MA) and probed for the epitope FLAG (DYKDDDK) tag on all Y1
constructs using the primary antibody anti-FLAGH M2 (Stratagene,
CA). To detect the Y2 fragment, the primary antibody was anti-
GFP (Roche, IN). As a cytoplasmic fractionation marker, the
primary antibody anti-GroEL (Sigma) was used. The secondary
antibody was always anti-mouse IgG-HRP (Promega, WI). HRP
detection was via chemiluminescence using the Immun-Star HRP
Chemiluminescent Kit (BioRad) and captured on X-Omat Film
(Kodak). For substrate/chaperone co-purification and membrane
co-localization protocols, see Supplemental Methods S1.
Supporting Information
Figure S1 RFP BiFC reports DmsA-DmsD interaction. (a) BiFC
analysis using split mRFP1Q66T in wt TG1 cells. Shown are
fluorescence microscopy images of TG1 cells co-expressing ssDmsA-
R1 and DmsD-R2, as well as controls co-expressing unfused R1
and/or R2 as indicated. (b) Quantification of mRFP1Q66T BiFC
signals using a fluorescence microplate reader for the same cells as in
(a). Whole cell fluorescence values were normalized to the
fluorescence emission from wt TG1 cells expressing ssDmsA-R1/
DmsD-R2 and reported as the average of 3 replicate measurements
(n=3). Error bars represent the sem.
Found at: doi:10.1371/journal.pone.0009225.s001 (1.62 MB TIF)
Figure S2 Co-purification of substrate/chaperone pairs from the
cytoplasm of E. coli. (a) Purification of 8xHis-DmsD-Y2 from TG1
DtatABCE cells co-expressing DmsA-Y1. Lanes were loaded with
(from left to right): MW, molecular weight ladder; 1, cell lysate; 2,
50k MWCO filtrate; 3, flow-through; 4, 5 mM imidazole; 5,
60 mM imidazole; 6, 80 mM imidazole; 7, 100 mM imidazole; 8,
150 mM imidazole; 9, 1000 mM imidazole. Numbers to the left
correspond to the MW of the ladder proteins. Gel was stained with
BioRad BioSafe Coomassie Blue and imaged on a BioRad
ChemiDoc. (b) UV illumination of elution fractions corresponding
to lanes 5–9 in (a). (c) Native PAGE analysis of elution fractions
corresponding to lanes 6–9 in (a) from DmsA-Y1 expressing cells.
Also shown are similar elution fractions generated from cells co-
expressing ssDmsA-Y1 with 8xHis-DmsD-Y2. PAGE gel was
illuminated using UV transilluminator. (d) Western blot analysis of
samples in (c) using anti-FLAG antibodies that recognize the C-
terminal FLAG tag on DmsA-Y1 and ssDmsA-Y1.
Found at: doi:10.1371/journal.pone.0009225.s002 (3.37 MB TIF)
Figure S3 Isolation of gain-of-function chaperones. (a) Cell
fluorescence of DmsD-Y2 library isolates (HYF, YLF, FYL, IVT)
following co-expression with ssDmsA-Y1 in TG1 cells. Two
previously characterized mutants (R15C/L75S and W87Y) were
included for comparison. Unfused Y2 co-expressed with ssDmsA-
Y1 served as a negative control. (b) Cell fluorescence of the same
library isolates described in (a) but co-expressed with full-length
DmsA-Y1 in TG1 cells. All median fluorescence values obtained
via flow cytometric analysis were normalized to the signal obtained
Imaging Tat Interactions
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reported as the average of 3 replicate measurements (n=3). Error
bars represent the sem. (c) Western blot analysis of the cytoplasmic
(c) or periplasmic (p) fractions isolated from cells co-expressing
ssDmsA-Y1 with the DmsD-Y2 variants as indicated. GroEL
served as a fractionation marker for cytoplasmic protein.
Found at: doi:10.1371/journal.pone.0009225.s003 (1.00 MB TIF)
Figure S4 Co-localization of ssDmsA-Y1 with TatC in E. coli
membranes. Western blot analysis of soluble and membrane
fractions isolated from TG1 DtatABCE cells expressing ssDmsA-Y1
alone or co-expressing ssDmsA-Y1 with TatC-Y2. Blot was
probed with anti-FLAG antibodies for detection of ssDmsA-Y1.
Numbers to the left indicate the molecular weight (MW) of the
ladder proteins. Two separate aliquots from the fraction collected
from the top of the 70% sucrose layer (total membrane fraction)
were analyzed side-by-side on the blot. An equivalent amount of
soluble or membrane proteins was added to each lane.
Found at: doi:10.1371/journal.pone.0009225.s004 (0.58 MB TIF)
Materials and Methods S1 Text file.
Found at: doi:10.1371/journal.pone.0009225.s005 (0.05 MB
DOC)
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